Finke J, Schmoor C, Stelljes M, Burchert A, et al. Thiotepa-fludarabine-treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial. Bone Marrow Transplant 2022;57:1664-1670.
PMID: 35982219